AZD2820

DRUG2 trials

Sponsors

AstraZeneca

Conditions

HealthyObesity

Phase 1

To Assess the Safety, Tolerability and Pharmacokinetics of AZD2820 After Single Ascending Doses

CompletedNCT01332214

AstraZenecaHealthy

Start: 2011-05-31End: 2011-11-30Updated: 2011-11-21

To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses

TerminatedNCT01469923

AstraZenecaObesity

Start: 2012-03-31End: 2012-12-31Updated: 2012-07-24